ERICA KUEBER: Open Payments
NPI 1841352697 · AUBURN, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$779 in 41 payments from 11 companies in 2025. Trend: 2023 $780 · 2024 $591 · 2025 $779
Food & beverage: $779
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $184 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $172 |
| Amgen Inc. | 1 | $125 |
| AstraZeneca Pharmaceuticals LP | 4 | $69 |
| Novo Nordisk Inc | 3 | $51 |
| Lilly USA, LLC | 3 | $47 |
| Exact Sciences Corporation | 2 | $43 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $41 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Corcept Therapeutics | 1 | $16 |
Products named: CAPLYTA, EVENITY, VRAYLAR, QULIPTA, BREZTRI, MOUNJARO, Cologuard Collection Kit, Kerendia.
Industry payments across IN — which companies pay providers there.
